Ya-Juan Gao, MD^1*, Kaini Shen, MD^1*, Long Chang^1*, Jun Feng, MD^1*, Yueying Mao^1*, Lu Zhang, MD^1*, Xinxin Cao, MD^1*, Daobin Zhou^1* and Jian Li, MD²

¹Department of Hematology, Chinese Academy of Medical Sciences & Peking Union Medical College, Peking Union Medical College Hospital, Beijing, China
²Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

Manisha Bhutani, MD¹, Myra Robinson, MSPH^2*, Shebli Atrash, MD^1*, Nicole Watts, PharmD^3*, Barry Paul, MD, MS¹, Saurabh Chhabra, MD, MS⁴, Neha Korde, MD⁵, Xhevahire Begic, MSPH^6*, David M Foureau, PhD^7*, David J. Chung, MD, PhD⁸, Mauricio Pineda-Roman, MD¹, Brinda Koya, MD^1*, Cindy Varga, MD, BSc¹, Jing Ai, MD, PhD⁹, Natonya Daniels^1*, Sarah Norek, BSN, RN^6*, Sara A Sutton, MSN, RN^6*, Michelle B Anderson^2*, Ashley N Jewell, MS, MLS (ASCP)^1*, Paul W Eldridge, PhD^1*, Donna Acampora, BSN, RN^6*, James T Symanowski, PhD^2*, Luciano J. Megala Costa, MD, PhD¹⁰, Saad Usmani, MD⁵ and Peter M. Voorhees, MD¹

¹Department of Hematologic Oncology & Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC
²Department of Cancer Biostatistics, Levine Cancer Institute, Atrium Health, Charlotte, NC
³Department of Pharmacy, University of Alabama at Birmingham Hospital, Birmingham, AL
⁴Division of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
⁵Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁶Clinical Trials, Levine Cancer Institute, Atrium Health, Charlotte, NC
⁷Immune Monitoring Core Laboratory, Levine Cancer Institute, Atrium Health, Charlotte, NC
⁸Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁹Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC
¹⁰Department of Medicine, Division of Hematology/Oncology, University of Alabama at Birmingham, Birmingham, AL

Wenjiao Tang, MD^1*, Yan Li, MD^1*, Qiushi Liang, MD, PhD^1*, Ying Qu, PhD^1*, Li Zhang, MD^1*, Yuzhang Liu, MD^2*, Baijun Fang, M.D., Ph.D.^3*, Zeng Yun, MD, PhD^4*, Xiaobo Du, MD^5*, Yaming Xi, MD^6*, Ting Wang, MD^6*, Xin Li, MD⁷, Jie Huang, MD^8*, Wenbin Qian, MD, PhD⁹, Zhen Cai, MD^10*, Qingwei Zhao, MD^11*, Yue Lv, MD^12* and Ting Niu¹³

¹Department of Hematology, Institute of Hematology, West China Hospital Sichuan University, Chengdu, China
²Henan Cancer Hospital, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China
³Department of Hematology, the Affiliated Cancer Hospital of Zhengzhou University and the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
⁴Department of Hematology, First Affiliated Hospital of Kunming Medical University, Hematology Research Center of Yunnan Province, Kunming, China
⁵Mianyang Central Hospital, Mianyang, China
⁶The First Hospital of Lanzhou University, Lanzhou, China
⁷Department of Hematology, The Third Xiangya Hospital, Central South University, Changsha, China
⁸The Third Xiangya Hospital, Central South University, Changsha, China
⁹Department of Hematology, The Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China
¹⁰The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
¹¹Department of Clinical Pharmacy, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
¹²Sun Yat-sen University Cancer Center, Guangzhou, China
¹³West China Hospital of Sichuan University, Chengdu, Sichuan, China

Sagar Lonial, MD¹, Al-Ola Abdallah, MD², Faiz Anwer, MD³, Ashraf Z. Badros, MD⁴, Manisha Bhutani, MD⁵, Abdullah Khan, MBBS, MSc⁶, Brea Lipe, MD⁷, Albert Oriol^8*, Darrell White, MD⁹, Michael Amatangelo, PhD^10*, Kexin Jin^10*, Mark Masin^10*, Vi Nguyen^10*, Alpesh Amin^10*, Paulo Maciag, MD PhD^10* and Niels WCJ Van De Donk, MD¹¹

¹Winship Cancer Institute, Emory University, Atlanta, GA
²University of Kansas Medical Center, Kansas City, KS
³Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
⁴Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, MD
⁵Division of Plasma Cell Disorders, Department of Hematologic Oncology & Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC
⁶The James Cancer Hospital and Solove Research Institute, Ohio State University Comprehensive Cancer Center, Columbus, OH
⁷The Department of Medicine, University of Rochester Medical Center, Rochester, NY
⁸Catalan Institute of Oncology and Josep Carreras Institute, Hospital Germans Trias i Pujol, Badalona, AZ, Spain
⁹Dalhousie University and Queen Elizabeth II Health Sciences Centre, Halifax, NS, Canada
¹⁰Bristol Myers Squibb, Princeton, NJ
¹¹Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Department of Hematology, Amsterdam, Netherlands, and Cancer Center Amsterdam, Amsterdam, Netherlands

Peter M. Voorhees, MD¹, Anita D'Souza, MD, MS², Katja C. Weisel, MD³, David Duane Hurd, MD⁴, Raphael Teipel, MD^5*, Alfred Chung, MD⁶, Cesar Rodriguez, MD⁷, Sascha A. Tuchman, MD, MHS⁸, Neha Korde, MD⁹, Hana Safah, MD¹⁰, Orlando F. Bueno, MD, PhD¹¹, Neil Pumford, MB ChB, MBA^12*, Tanya S Rosenberg, MD^12*, Rajvineeth Kumar Pothacamury, MD^12*, Jeremy A. Ross, PhD^12*, Akshanth R. Polepally, PhD^12*, Shane Lee, MS^12*, Ziyi Jin, MS^12*, Chetasi Talati, MD^12*, Ravi Vij, MBBS, MBA^13* and Shaji K Kumar, MD¹⁴

¹Plasma Cell Disorders Section, Department of Hematologic Oncology & Blood Disorders, Levine Cancer Institute, Atrium Health/Wake Forest Baptist, Charlotte, NC
²Division of Hematology/Oncology, Department of Medicine, Froedtert & Medical College of Wisconsin Cancer Center, Milwaukee, WI
³Department of Oncology, Hematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
⁴Section of Hematology and Oncology, Department of Medicine, Wake Forest University School of Medicine, Winston-Salem, NC
⁵Medizinische Klinik I, Universitätsklinikum Dresden, Dresden, Germany
⁶Division of Hematology/Oncology, Department of Medicine, University of California San Francisco,, San Francisco, CA
⁷Medical Oncology and Hematology, Wake Forest University School of Medicine, Winston-Salem, NC
⁸Division of Hematology, The University of North Carolina at Chapel Hill, Chapel Hill, NC
⁹Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, NY, NY
¹⁰Section of Hematology and Medical Oncology, Tulane Medical Center, New Orleans, LA
¹¹AbbVie, Inc., North Chicago, IL
¹²AbbVie Inc., North Chicago, IL
¹³Washington University School of Medicine, St Louis, MO
¹⁴Division of Hematology, Mayo Clinic, Rochester, MN

Evangelos Terpos, MD, PhD¹, Maria Gavriatopoulou, MD^2*, Ioannis Ntanasis-Stathopoulos, MD^1*, Panagiotis Malandrakis, MD^2*, Despina Fotiou, MD^2*, Nikolaos Kanellias, MD^1*, Magdalini Migkou, MD^2*, Foteini Theodorakakou, MD^2*, Vasiliki Spiliopoulou, MD^1*, Rodanthi Syrigou, MD^1*, Evangelos Eleutherakis Papaiakovou, MD^1*, Stavros Gkolfinopoulos, MD, MSc^3*, Kyriaki Manousou, MSc^3*, Efstathios Kastritis, MD^1* and Meletios A. Dimopoulos, MD¹

¹Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
²Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece
³Health Data Specialists, Dublin, Ireland

Sebastian Grosicki, MD, PhD¹, Ulf-Henrik Mellqvist², Łukasz Pruchniewski, MD, PhD^3*, Jacob Crafoord, MD^4*, Suzanne Trudel⁵, Chang-Ki Min, MD, PhD^6*, Darrell White, MD^7*, Adrian Alegre, MD, PhD⁸, Markus Hansson, MD, PhD^9*, Takashi Ikeda, MD, PhD^10*, Kazutaka Sunami¹¹, Eric Leip, PhD^12*, Arthur Kudla, PhD^13*, Gregory Finn, PhD^14* and Youngil Koh, MD, PhD¹⁵

¹Department of Hematology and Cancer Prevention, Medical University of Silesia, Katowice, Poland
²Department of Hematology, South Elfsborg Hospital, Borås, Sweden
³Centrum Medyczne Pratia Poznań, Poznań, Poland
⁴Department of Hematology, Örebro University Hospital, Örebro, Sweden
⁵Division of Hematology, Princess Margaret Cancer Center, Toronto, ON, Canada
⁶Department of Hematology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)
⁷Division of Hematology, Dalhousie University and Queen Elizabeth II Health Sciences Centre, Halifax, NS, Canada
⁸Department of Hematology, Univeritary Hospital La Princesa, Madrid, Madrid, Spain
⁹Department of Hematology, Sahlgrenska University Hospital, Göteborg, Sweden
¹⁰Division of Hematology and Stem Cell Transplantation, Shizuoka Cancer Center, Shizuoka, SHZ, Japan
¹¹Department of Hematology, National Hospital Organization Okayama Medical Center, Okayama, Japan
¹²Pfizer Inc., Cambridge, MA
¹³Pfizer Inc, Cambridge, MA
¹⁴Early Clinical Development, Pfizer Inc, Cambridge, MA
¹⁵Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea, Republic of (South)

Pellegrino Musto¹, Monique C. Minnema, MD, PhD², Wilfried W.H. Roeloffzen, MD, PhD^3*, Andrea Capra, MScEng^4*, Bronno van der Holt, PhD^5*, Annette Juul Vangsted, MD^6*, Annemiek Broijl, MD, PhD^7*, Fredrik Schjesvold, MD, PhD⁸, Thomas Lund, MD, PhD^9*, Trine Silkjaer, MD, PhD^10*, Reuben Benjamin, MD, PhD¹¹, Mariella Grasso, MD^12*, Ka Lung Wu, MD¹³, Jo Caers, PhD¹⁴, Michele Cavo, MD^15*, Roman Hájek, MD, PhD¹⁶, Benedetto Bruno, MD, PhD^17*, Alain Gadisseur, MD, PhD^18*, Giuseppe Pietrantuono, MD^19*, Massimo Offidani, MD^20*, Luděk Pour, MD^21*, Pieter Sonneveld, MD²², Mario Boccadoro, MD^4* and Niels W.C.J. van de Donk, MD, PhD²³

¹Department of Emergency and Organ Transplantation, "Aldo Moro" University School of Medicine and Unit of Hematology and Stem Cell Transplantation, AOUC Policlinico, Bari, Italy
²University Medical Center Utrecht, Department of Hematology, Utrecht University, Utrecht, Netherlands
³Department of Hematology, University Medical Center Groningen, University Groningen, Groningen, Netherlands
⁴Division of Hematology, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino, Italy
⁵HOVON Data Center, Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands
⁶Dept. Hematology, Rigshospitalet, Copenhagen University, Copenhagen, Denmark
⁷Department of Hematology, Erasmus Medical Center, Rotterdam, Netherlands
⁸Oslo Myeloma Center, Department of Hematology, Oslo University Hospital and KG Jebsen Center for B cell malignancies, University of Oslo, Oslo, Norway
⁹Odense Hospital, Odense, Denmark
¹⁰Aarhus University Hospital, Aarhus, Denmark
¹¹King’s College Hospital, London, United Kingdom
¹²Azienda Ospedaliera S. Croce e Carle, Cuneo, Italy
¹³Department of Hematology, ZNA Stuivenberg, Antwerp, Belgium
¹⁴Department of Hematology, CHU Liege, Liege, Belgium
¹⁵IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli", Bologna, Italy
¹⁶Department of Hematooncology, University Hospital Ostrava and Department of Hematooncology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic
¹⁷Division of Hematology, Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy
¹⁸Department of Haematology, Antwerp University Hospital, Edegem, Belgium
¹⁹Centro di Riferimento Oncologico della Basilicata (IRCCS-CROB), Rionero in Vulture (PZ), Italy
²⁰AOU Ospedali Riuniti di Ancona, Ancona, Italy
²¹Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, Brno, Czech Republic
²²Erasmus MC Cancer Institute, Department of Hematology, Rotterdam, Netherlands
²³Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Hematology, Cancer Center Amsterdam, Amsterdam, Netherlands

Hang Quach¹, Gurdeep Parmar, MBBS², Enrique M. Ocio³, H. Miles Prince, MD⁴, Albert Oriol, MD^5*, Nobuhiro Tsukada, MD, PhD⁶, Kazutaka Sunami⁷, Pierre Bories^8*, Sumit Madan, MD⁹, Dorothee Semiond, PhD, PharmD^10*, Disa Yu^10*, Sandrine Macé, PhD^11*, Florence Suzan, MD^11* and Philippe Moreau, MD^12*

¹Department of Clinical Haematology, St Vincent's Hospital, University of Melbourne, Melbourne, VIC, Australia
²Illawarra Cancer Care Centre, Wollongong, NSW, Australia
³University Hospital Marqués de Valdecilla (IDIVAL), University of Cantabria, Santander, Spain
⁴Molecular Oncology and Cancer Immunology, Epworth Healthcare and University of Melbourne, Melbourne, Australia
⁵Institut Català d’Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Barcelona, Spain
⁶Department of Hematology, Japanese Red Cross Medical Center, Tokyo, Japan
⁷Department of Hematology, National Hospital Organization Okayama Medical Center, Okayama, Japan
⁸Early Phase Unit, Institut Claudius Regaud, Institut Universitaire du Cancer Toulouse, Toulhouse, France
⁹Banner MD Anderson Cancer Center at Banner University Medical Center, Phoenix, AZ
¹⁰Sanofi, Cambridge, MA
¹¹Sanofi, Vitry-Sur-Seine, France
¹²Hematology Department, University Hospital Hôtel-Dieu, Nantes, France

Alexander M Lesokhin, MD^1,2, Joshua Richter, MD³, Suzanne Trudel⁴, Adam D Cohen, MD⁵, Andrew Spencer⁶, Peter A Forsberg⁷, Jacob P Laubach, MD^8*, Sheeba K Thomas, MD⁹, Nizar J. Bahlis, MD¹⁰, Luciano J. Megala Costa, MD, PhD¹¹, Paula Rodriguez Otero, MD, PhD^12*, Maria-Victoria Mateos, MD¹³, Jesus G Berdeja, MD¹⁴, Rayan Kaedbey, MD¹⁵, Amrita Y. Krishnan, MD, FACP¹⁶, Rafael Fonseca¹⁷, Voleak Choeurng^18*, James Cooper^18*, Teiko Sumiyoshi^18*, Chihunt Wong^18* and Simon J Harrison, MD¹⁹

¹Memorial Sloan Kettering Cancer Center, New York, NY
²Weill Cornell Medical College, New York, NY
³Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
⁴Princess Margaret Cancer Centre and University of Toronto, Toronto, ON, Canada
⁵Abramson Cancer Center and University of Pennsylvania, Philadelphia, PA
⁶Clinical Hematology, Alfred Health, Melbourne, Australia
⁷University of Colorado School of Medicine, Aurora, CO
⁸Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
⁹The University of Texas MD Anderson Cancer Center, Houston, TX
¹⁰University of Calgary, Calgary, AB, Canada
¹¹O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL
¹²Clínica Universidad de Navarra, Pamplona, Spain
¹³Instituto de Investigación Biomédica de Salamanca (IBSAL), Hospital Universitario de Salamanca, Salamanca, Spain
¹⁴Sarah Cannon Research Institute, Nashville, TN
¹⁵Jewish General Hospital, McGill University, Montreal, QC, Canada
¹⁶City of Hope, Duarte, CA
¹⁷Mayo Clinic in Arizona, Phoenix, AZ
¹⁸Genentech, Inc., South San Francisco, CA
¹⁹Peter MacCallum Cancer Centre, Sir Peter MacCallum Department of Oncology, Melbourne University, and The Royal Melbourne Hospital, Melbourne, Australia

Yaël C. Cohen^1*, Philippe Moreau, MD^2*, Jaszianne Tolbert³, Xiang Qin^3*, Xuewen Ma^3*, Diego Vieyra^3*, Angelique Langlois^3*, Christelle Courtoux^3*, William Terry³, Lixia Pei^4*, Christoph Heuck^3* and Peter Voorhees^5*

¹Tel Aviv Sourasky (Ichilov) Medical Center, and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
²University Hospital Hotel-Dieu, Nantes, France
³Janssen Research & Development, Spring House, PA
⁴Janssen Research & Development, Raritan, NJ
⁵Atrium Health Levine Cancer Institute, Charlotte, NC

Niels W.C.J. Van De Donk, MD, PhD¹, Monique C. Minnema, MD, PhD², Bronno van der Holt, PhD^3*, Fredrik Schjesvold, MD, PhD⁴, Ka Lung Wu, MD⁵, Andrea Capra, MScEng^6*, Annemiek Broijl, MD, PhD^7*, Wilfried W.H. Roeloffzen, MD, PhD^8*, Alain Gadisseur, MD, PhD^9*, Giuseppe Pietrantuono, MD^10*, Ludek Pour, MD, Prof, PhD^11*, Vincent H.J. van der Velden, PhD^12*, Thomas Lund, MD, PhD^13*, Massimo Offidani, MD¹⁴, Mariella Grasso, MD^15*, Luisa Giaccone, MD, PhD^16*, Michele Cavo, MD^17*, Trine Silkjaer, MD, PhD^18*, Jo Caers, PhD¹⁹, Sonja Zweegman, MD, PhD²⁰, Roman Hájek, MD, PhD²¹, Reuben Benjamin^22*, Annette Juul Vangsted, MD^23*, Mario Boccadoro, MD²⁴, Francesca Gay, MD, PhD²⁵, Pieter Sonneveld, MD²⁶ and Pellegrino Musto²⁷

¹Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Hematology, Amsterdam, Netherlands
²Department of Hematology, University Medical Center, Utrecht, Netherlands, Utrecht, Netherlands
³HOVON Data Center, Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands
⁴Oslo Myeloma Center, Department of Hematology, Oslo University Hospital, Oslo, Norway, and KG Jebsen Center for B Cell Malignancies, University of Oslo, Oslo, Norway
⁵Department of Hematology, ZNA Stuivenberg, Antwerp, Belgium
⁶Division of Hematology, Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy
⁷Department of Hematology, Erasmus Medical Center, Rotterdam, Netherlands
⁸Department of Hematology, University Medical Center Groningen, University Groningen, Groningen, Netherlands
⁹Department of Haematology, Antwerp University Hospital, Edegem, Belgium
¹⁰Centro di Riferimento Oncologico della Basilicata (IRCCS-CROB), Rionero in Vulture (PZ), Italy
¹¹Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, Brno, Czech Republic
¹²Department of Immunology, Erasmus Medical Center, University Medical Center, Rotterdam, Netherlands
¹³Odense Hospital, Odense, Denmark
¹⁴Hematology Clinic, AOU Ospedali Riuniti di Ancona, Ancona, Italy
¹⁵Azienda Ospedaliera S. Croce e Carle, Cuneo, Italy
¹⁶Department of Oncology and Hematology, SSD Stem Cell Transplant Center, A.O.U. Città della Salute e della Scienza di Torino, Turin, Italy
¹⁷Seràgnoli Institute of Hematology, Bologna University School of Medicine, Bologna, Italy
¹⁸Aarhus University Hospital, Aarhus, Denmark
¹⁹Department of Hematology, CHU de Liège, Liege, Belgium
²⁰Department of Hematology, Cancer Center Amsterdam, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, Netherlands
²¹Department of Hemato-oncology, University Hospital Ostrava and Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic
²²Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, London, United Kingdom
²³Dept. Hematology, Rigshospitalet, Copenhagen University, Copenhagen, Denmark
²⁴Department of Molecular Biotechnologies and Health Sciences, University of Torino, Torino, Italy
²⁵Myeloma Unit, Division of Hematology, University of Torino, A.O.U. S. Giovanni Battista, Torino, Italy
²⁶Department of Hematology, Erasmus MC, Rotterdam, Netherlands
²⁷Department of Emergency and Organ Transplantation, "Aldo Moro" University School of Medicine, and Unit of Hematology and Stem Cell Transplantation, Hematology-University of Bari, Bari, Italy

Arthur Bobin^1*, Jerome Lambert, MD, PhD^2*, Aurore Perrot, MD, PhD^3*, Salomon Manier, MD, PhD⁴, Lydia Montes^5*, Arnaud Jaccard^6*, Lionel Karlin^7*, Pascal Godmer, MD^8*, Denis Caillot, MD^9*, Cyrille Hulin^10*, Thomas Chalopin, MD^11*, Christophe Roul, MD^12*, Clara Mariette, MD^13*, Sophie Rigaudeau, MD^14*, Claire Dingremont^15*, Alberto Santagostino^16*, Mamoun Dib, MD^17*, Margaret Macro, MD^18*, Mourad Tiab^19*, Kamel Laribi, MD^20*, Emmanuelle Bourgeois-Petit, MD^21*, Claire Calmettes, MD^22*, Frederique Orsini^23*, Reza Tabrizi, MD^24*, Laure Vincent, MD^25*, Mohamad Mohty, MD PhD^26,27, Cyrille Touzeau^28*, Jill Corre^29*, Philippe Moreau, MD^30*, Thierry Facon^31*, Herve Avet Loiseau, MD, PhD³² and Xavier Leleu, MD, PhD³³

¹Department of Hematology and Cell therapy, INSERM CIC 1402, Poitiers University Hospital, Poitiers, France
²Biostatistics Department, University of Paris, AP-HP, Saint Louis Hospital, Paris, FRA
³Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France
⁴Department of Medical Oncology, Hopital Claude Huriez, CHU Lille, Lille, France
⁵Hematology department, CHU Amiens, Amiens, France
⁶Hematology department, Limoges University Hospital, Limoges, France
⁷Centre Hospitalier Lyon Sud, Lyon, France
⁸Clinical Hematology, Centre Hospitalier Bretagne Atlantique, Vannes, France
⁹Hematology Department, Dijon University Hospital, Dijon, France
¹⁰Hôpital Haut Leveque, University Hospital, Pessac, France
¹¹Department of Hematology and Cellular Therapy, Tours University Hospital, UMR CNRS, François Rabelais University, Tours, France
¹²La Rochelle Hospital, La Rochelle, FRA
¹³Service d'Hématologie, CHU de Grenoble, Grenoble, France
¹⁴Centre Hospitalier de Versailles André Mignot, Le Chesnay, France
¹⁵Service de médecine interne, Centre Hospitalier de Tarbes, Tarbes, France
¹⁶Hematology, CH de Troyes, Troyes, France
¹⁷Hématologie - CHU - Hôpital du Bocage, Angers, France
¹⁸Haematology Department, Caen University Hospital, Caen, France
¹⁹CH la Roche Sur Yon, La Roche Sur Yon Cedex 9, France
²⁰Hématologie clinique, CH Le Mans, Le Mans, France
²¹Hematology, Hôpital Saint Vincent de Paul, Lille Cedex, FRA
²²Oncologie-Hématologie, Centre Hospitalier de Périgueux, Périgueux, France
²³Service Hématologie, CH Annecy, ANNECY, France
²⁴Hôpital Haut-Leveque C.H.U. de Bordeaux, Pessac, France
²⁵Department of Hematology, Montpellier University Hospital, Montpellier, France
²⁶EBMT Paris study office / CEREST-TC, Paris, France, Department of Hematology, Saint Antoine Hospital, Paris, France, INSERM UMR 938, Sorbonne University, Paris, France
²⁷Department of Haematology, Saint Antoine Hospital, Paris, France
²⁸Hematology Department, Nantes University Hospital, Nantes, France
²⁹Unité de Génomique du Myélome, IUCT- Oncopole, Toulouse, France
³⁰Hematology Department, University Hospital Hôtel-Dieu, Nantes, France
³¹Bordeaux Hospital University Center (CHU), Lille, France
³²Unite de Genomique du Myelome, IUC-Oncopole, Toulouse, France
³³Department of Oncology, Hematology and Cellular Therapy, Poitiers University Hospital, Poitiers, France

Yael C Cohen^1,2*, Moshe E Gatt³, Efrat Luttwak, MD^4*, Noa Lavi, MD^5*, Chezi Ganzel^6*, Evgeni Chubar, MD^7*, Ory Rouvio, MD^8*, Iuliana Vaxman, MD, BA^9,10*, Oren Pasvolsky, MD^10*, Mouna Ballan^11*, Tamar Tadmor, MD^12*, Anatoly Nemets, MD^13*, Osnat Jarchowsky^14*, Olga Shvetz, MD^15*, Ofer Shpilberg, MD, MPH^16*, Najib Dally, MD^17*, Merav Leiba, MD^18*, Assaf Weiner, PhD^19*, Mor Zada, MSc^20*, Shuang-Yin Wang^21*, Chamutal Gur^22*, Noa Lowenton-Spier^4*, Liron Goor-Porges^4*, Ido Amit, PhD^19* and Irit Avivi, MD^23*

¹Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
²Tel Aviv Sourasky (Ichilov) Medical Center, and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
³Department of Hematology, Hadassah Medical Center and Faculty of Medicine, Hebrew University, Jerusalem, Israel
⁴Department of Hematology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
⁵Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel
⁶Shaare Zedek Medical Center, Jerusalem, Israel
⁷Head, Blood Bank, HaEmek Medical Center, Afula, Israel
⁸Soroka Medical center, Be'er She'va, Israel
⁹Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
¹⁰Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petah Tikva, Israel
¹¹hematology, Carmel Medical Center, Haifa, Israel
¹²Bnai Zion Medical Center, Haifa, Israel
¹³Barzilai Medical Center, Ashkelon, Israel
¹⁴Hematology Department, Meir Medical Center, Kfar Saba, ISR
¹⁵Hematology, Kaplan Medical Center, affiliated with Hadassah and Hebrew University Medical School, Rehovot, Israel
¹⁶Institute of Hematology/Clinic of Histiocytic Neoplasms, Assuta Medical Centers, Tel-Aviv, Israel
¹⁷Ziv Medical Center, Institute of hematology and blood bank, Safed, Israel
¹⁸Assuta University Hospital, Faculty of Health Science, Ben-Gurion University of the Negev, Ashdod, Israel
¹⁹Weizmann Institute of Science, Rehovot, Israel
²⁰Weizmann Institute of Science, Tel Aviv, Israel
²¹Wetzmann Institute of Science, Rehovot, Israel
²²The Hebrew University Jerusalem, Jerusalem, ISR
²³BMT Unit, Tel Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

Hans C. Lee, MD¹, Gregory P. Kaufman, MD^1*, Lei Feng, MS^2*, Astrid Murga^1*, Ralph J. Johnson, PhD^1*, Donna M. Weber, MD¹, Sheeba K Thomas, MD¹, Qaiser Bashir, MD³, Muzaffar H Qazilbash, MD³, Swaminathan P. Iyer, MD¹, Krina Patel, MD, MSc¹, Melody R. Becnel, MD¹, Elisabet E. Manasanch, MD¹ and Robert Z. Orlowski, MD, PhD¹

¹Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX

Smith Giri, MD, MHS¹, Saurabh Chhabra, MD, MS², Eva Medvedova, MD^3*, Bhagirathbhai Dholaria, MBBS⁴, Timothy Martin Schmidt, MD⁵, Kelly N. Godby, MD^6*, Rebecca Silbermann, MD, MMS⁷, Binod Dhakal, MBBS⁸, Susan Bal^9*, Anita D'Souza, MD, MS¹⁰, Aric C. Hall, MD^11*, Pamela Hardwick, RN^12*, Jim Omel, MD^13*, Robert Frank Cornell, MD^14*, Natalie Callander, MD¹⁵, Parameswaran Hari, MD, MRCP¹⁶ and Luciano J. Megala Costa, MD, PhD¹⁷

¹Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL
²Division of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
³Knight Cancer Institute, Oregon Health & Science University, Portland, OR
⁴Department of Medicine, Division of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, TN
⁵Carbone Cancer Center, University of Wisconsin, Madison, WI
⁶Department of Medicine, Division of Hematology/Oncology, University of Alabama at Birmingham, Birmingham, AL
⁷School of Medicine Oregon Health and Science University, Portland, OR
⁸Medical College of Wisconsin, Division of Hematology/Oncology, Department of Medicine, Milwaukee, WI
⁹University of Alabama at Birmingham Hospital, Birmingham, AL
¹⁰Center for International Blood and Marrow Transplant Research, Department of Medicine, The Medical College of Wisconsin Inc., Milwaukee, WI
¹¹Division of Hematology/Oncology, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI
¹²University of Alabama at Birmingham, Birmingham, AL
¹³The Central Nebraska Myeloma Support Group, Grand Island, NE
¹⁴Vanderbilt University, Nashville, TN
¹⁵University of Wisconsin, Madison, WI
¹⁶Medical College of Wisconsin, Milwaukee, WI
¹⁷University of Alabama at Birmingham Hospital, Vestavia, AL

Shaji K Kumar, MD¹, Craig C Hofmeister, MD², Noa Biran, MD³, Gurbakhash Kaur, MD⁴, Jing Christine Ye, MD^5*, Jeffrey A. Zonder, MD⁶, Umar Syed, MS^7*, Jennifer Yesil, MSc^7*, Karen Woolley^7*, George Mulligan, PhD^7* and Hearn J. Cho, MD, PhD^7,8

¹Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN
²Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA
³Hackensack Meridian Health John Theurer Cancer Center, Hackensack, NJ
⁴Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX
⁵Rogel Cancer Center, University of Michigan, Ann Arbor, MI
⁶Karmanos Cancer Institute, Wayne State University, Detroit, MI
⁷Multiple Myeloma Research Foundation, Norwalk, CT
⁸Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY

Anupama Kumar, MD¹, Aaron S Rosenberg, MD², Michelle Padilla^3*, Nina Shah, MD⁴, Lindsey Sirianni^1*, Lin Liu, PhD^5*, Yuwei Cheng^1*, Emily Pittman, PhD^3*, Dimitrios Tzachanis, MD, PhD⁶, Sarah Larson, MD⁷, Carolyn Mulroney, MD⁸, Edward D. Ball, MD^9* and Caitlin Costello, MD¹⁰

¹University of California, San Diego, La Jolla, CA
²Department of Internal Medicine, Division of Cellular Therapy, Bone Marrow Transplantation and Malignant Hematology, University of California Davis School of Medicine, Sacramento, CA
³Moores Cancer Center, University of California, San Diego, La Jolla, CA
⁴University of California San Francisco, San Francisco, CA
⁵University of California San Diego, La Jolla, CA
⁶University of California San Diego, San Diego, CA
⁷UCLA, Santa Monica, CA
⁸UCSD Moores Cancer Center, La Jolla, CA
⁹UCSD Moores Cancer Center, La Jolla
¹⁰University of California San Diego, Moores Cancer Center, La Jolla, CA

Efstathios Kastritis, MD^1*, Jeffrey V. Matous, MD², Emad Uddin Abro, MBBS, FRACP, FRCPA, BSc(Hons)^3*, P. Taylor Eves, PhD^4*, Cheng Zheng, PhD^5*, Tony Fiorino, MD, PhD^4* and Jesus Berdeja, MD⁶

¹Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece
²Colorado Blood Cancer Institute, Denver, CO
³Department of Haematology, Princess Alexandra Hospital, Brisbane, Australia
⁴Zentalis Pharmaceuticals, New York, NY
⁵Zentalis Pharmaceuticals, Inc., New York, NY
⁶Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN

Manisha Bhutani, MD¹, Myra Robinson, MSPH^2*, Barry Paul, MD, MS¹, Shebli Atrash, MD^1*, Cindy Varga, MD, BSc¹, Xhevahire Begic, MSPH^3*, David M Foureau, PhD^4*, Mauricio Pineda-Roman, MD¹, Brinda Koya, MD^1*, Sarah Norek, BSN, RN^3*, Sara A Sutton, MSN, RN^3*, Michelle B Anderson^2*, Donna Acampora, BSN, RN^3*, James T Symanowski, PhD^2*, Peter M. Voorhees, MD¹ and Saad Usmani, MD⁵

¹Department of Hematologic Oncology & Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC
²Department of Cancer Biostatistics, Levine Cancer Institute, Atrium Health, Charlotte, NC
³Clinical Trials, Levine Cancer Institute, Atrium Health, Charlotte, NC
⁴Immune Monitoring Core Laboratory, Levine Cancer Institute, Atrium Health, Charlotte, NC
⁵Levine Cancer Institute, New York, NY

Hao Zhao, MD^1*, Miaoyan Zhang^2*, Yanying Yu^1*, Xinxin Cao, MD^3*, Dao-Bin Zhou^1*, Lu Zhang, MD^1* and Jian Li, MD¹

¹Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
²Department of Hematology, Peking Union Medical College Hospital, Beijing, China
³Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, CA, China

Paula Rodríguez Otero, MD, PhD^1*, Nisha S. Joseph, MD², Shaji K Kumar, MD³, Hans C. Lee, MD⁴, Xavier Leleu, MD, PhD⁵, Salomon Manier, MD, PhD⁶, Meletios A. Dimopoulos, MD⁷, María Victoria Mateos, MD, PhD⁸, Albert Oriol^9*, Naresh Bumma, MD¹⁰, Weiying Gong, MD^11*, Pourab Roy, MD, PhD^11*, Karen Rodriguez Lorenc, MD¹¹, Glenn S. Kroog, MD^11* and Shawn M. Sarkaria, MD^11*

¹Department of Hematology, Clínica Universidad de Navarra, Pamplona, Spain
²Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Louisville, KY
³Mayo Clinic, Rochester, MN
⁴The University of Texas MD Anderson Cancer Center, Houston, TX
⁵Centre Hospitalier Universitaire de Poitiers, Poitiers, France
⁶CHRU Lille, Lille, France
⁷Alexandra, Gen. Hospital of Athens, Athens, Greece
⁸Hospital Clínico Universitario de Salamanca, Salamanca, Spain
⁹Institut Català d’Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Badalona, Spain
¹⁰The Ohio State University James Cancer Hospital and Solove Research Institute, Columbus, OH
¹¹Regeneron Pharmaceuticals, Inc., Tarrytown, NY

Cyrille Touzeau^1*, Ajai Chari^2*, Carolina Schinke³, Monique C. Minnema, MD, PhD⁴, Jesus Berdeja, MD⁵, Albert Oriol^6*, Niels WCJ Van De Donk, MD⁷, Paula Rodriguez Otero^8*, Elham Askari^9*, Maria-Victoria Mateos, MD¹⁰, Luciano J. Megala Costa, MD, PhD¹¹, Jo Caers^12*, Leo Rasche, MD^13*, Amrita Y. Krishnan, MD, FACP¹⁴, Deeksha Vishwamitra^15*, Xuewen Ma^15*, Xiang Qin^15*, Katharine S. Gries, PhD, PharmD^16*, Kelly Kato^16*, Michela Campagna^17*, Tara Masterson^15*, Brandi Hilder^15*, Jaszianne Tolbert¹⁵, Thomas Renaud^16*, Jenna D. Goldberg^16*, Chris Heuck, MD^15*, Philippe Moreau, MD^18* and Jesús San-Miguel, MD, PhD⁸

¹Centre Hospitalier Universitaire de Nantes, Nantes, France
²Mount Sinai School of Medicine, New York, NY
³Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR
⁴University Medical Center, Utrecht, Netherlands
⁵Sarah Cannon Research Institute, Nashville, TN
⁶Hospital Germans Trias I Pujol, Barcelona, Spain
⁷Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, Netherlands
⁸University of Navarra, Pamplona, Spain
⁹Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain
¹⁰University Hospital of Salamanca/IBSAL/CIC, Salamanca, Spain
¹¹University of Alabama at Birmingham Hospital, Vestavia, AL
¹²University of Liège, Liège, Belgium
¹³University Hospital of Würzburg, Würzburg, Germany
¹⁴City of Hope Comprehensive Cancer Center, Duarte, CA
¹⁵Janssen Research & Development, Spring House, PA
¹⁶Janssen Research & Development, Raritan, NJ
¹⁷Janssen-Cilag, Madrid, Spain
¹⁸University Hospital Hotel-Dieu, Nantes, France

Sikander Ailawadhi¹, Ricardo D Parrondo, MD², Betsy Laplant, MS^3*, Victoria R. Alegria^4*, Jamie B Elliott^5*, Taimur Sher, MD², Aneel Paulus, MD¹, Dustin Chapin^6*, Keisha Heslop^5*, Asher Chanan-Khan, MD⁷ and Vivek Roy, MD⁴

¹Division of Hematology and Oncology, Mayo Clinic, Jacksonville, FL
²Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, FL
³Division of Clinical Trials & Biostatistics, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN
⁴Mayo Clinic Comprehensive Cancer Center, Jacksonville, FL
⁵Department of Hematology-Oncology, Mayo Clinic, Jacksonville, FL
⁶Mayo Clinic, Jacksonville, FL
⁷Division of Hematology-Oncology, Mayo Clinic, Jacksonville, FL

Arthur Bobin^1*, Jerome Lambert, MD, PhD^2*, Stéphanie Ragot^3*, Aurore Perrot, MD, PhD^4*, Salomon Manier, MD, PhD⁵, Lionel Karlin^6*, Denis Caillot, MD^7*, Cyrille Hulin^8*, Lotfi Benboubker, MD^9*, Carla Araujo^10*, Jean Fontan, MD^11*, Thorsten Braun, MD, PhD¹², Clara Mariette, MD^13*, Elodie Scherman, MD^14*, Olivier Decaux, MD, PhD^15*, jean Sebastien Blade^16*, Faida Keddar^17*, Christophe Roul, MD^18*, Mamoun Dib, MD^19*, Jill Corre^20*, Frederique Orsini^21*, Laure Vincent, MD^22*, Mohamad Mohty, MD PhD²³, Cyrille Touzeau^24,25*, Philippe Moreau, MD^26*, Herve Avet Loiseau, MD, PhD²⁷ and Xavier Leleu, MD, PhD²⁸

¹Service d'Hématologie et de thérapie cellulaire, CHU de Poitiers, Poitiers, France
²Biostatistics Department, University of Paris, AP-HP, Saint Louis Hospital, Paris, FRA
³Inserm CIC 1402, University Hospital, Poitiers, France
⁴Centre Hospitalier Universitaire de Toulouse, Service d'Hématologie, Toulouse, France
⁵Department of Medical Oncology, Hopital Claude Huriez, CHU Lille, Lille, France
⁶Service d’Hématologie Clinique, Centre Hospitalier Lyon Sud, Pierre-Bénite, France
⁷Hematology Department, Dijon University Hospital, Dijon, France
⁸Department of Hematology, University Hospital Bordeaux, Bordeaux, France
⁹Hématologie Thérapie Cellulaire, CHRU TOURS, Tours, FRA
¹⁰Centre Hospitalier de la Cote Basque, Bayonne, France, Bayonne, FRA
¹¹Jean Minjoz Hôpital, Besancon, France
¹²Hematology, Avicenne Hospital, Bobigny, France
¹³Service d'Hématologie, CHU de Grenoble, Grenoble, France
¹⁴Hopital de Nimes, NIMES, FRA
¹⁵Service d'hématologie clinique, Centre Hospitalier Universitaire de Rennes, Rennes, France
¹⁶Hôpital d’Instruction des Armées Service de Médecine interne - Oncologie, Hôpital d’Instruction des Armées Sainte Anne, Toulon, France
¹⁷Centre Hospitalier Valenciennes, Valenciennes, France
¹⁸La Rochelle Hospital, La Rochelle, FRA
¹⁹Hématologie - CHU - Hôpital du Bocage, Angers, France
²⁰Toulouse, and CRCT, Toulouse, France, Toulouse, France
²¹Service Hématologie, CH Annecy, ANNECY, France
²²Department of Hematology, Montpellier University Hospital, Montpellier, France
²³EBMT Paris study office / CEREST-TC, Paris, France, Department of Hematology, Saint Antoine Hospital, Paris, France, INSERM UMR 938, Sorbonne University, Paris, France
²⁴Centre Hospitalier Universitaire (CHU) de Nantes, INSERM, Université de Nantes, Nantes, France
²⁵University Hospital Hôtel Dieu, Nantes Cedex 1, FRA
²⁶CHU de Nantes, Nantes, France
²⁷Unite de Genomique du Myelome, IUC-Oncopole, Toulouse, France
²⁸Department of Oncology, Hematology and Cellular Therapy, Poitiers University Hospital, Poitiers, France

Malin Hultcrantz, MD, PhD¹, Hani Hassoun, MD¹, Neha Korde, MD², Sham Mailankody, MBBS ³, Tala Shekarkhand, BS^1*, Miranda Burge^1*, Kylee H Maclachlan, MBBCh, PhD¹, Dhwani Patel, MD^1*, Urvi A Shah, MD¹, David J. Chung, MD, PhD⁴, Michael Scordo, MD⁵, Kelly Barnett, RN^6*, Jenna Blaslov, RN^1*, Meghan Salcedo, BSN, RN^6*, Julia Caple, RN^1*, Linh Tran, RN^7*, Selena Hamid^1*, Oscar B Lahoud, MD⁴, Heather Landau, MD⁴, Gunjan L. Shah, MD⁴, Sergio A Giralt, MD⁸, Andriy Derkach, PhD^9*, Carlyn Tan, MD¹⁰, Cody Peer, PhD^11*, William D. Figg Sr., PharmD^12*, Saad Usmani, MD¹, Ola Landgren, MD¹³ and Alexander M Lesokhin, MD¹

¹Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
²Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, NY, NY
³Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA, New York, NY
⁴Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁵Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center/New York, New York, NY
⁶Memorial Sloan Kettering Cancer Center, New York, NY
⁷Department of Medicine, Myeloma Service, Memorial Sloan Kettering Cancer Center, New York, NY
⁸Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, NY
⁹Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY
¹⁰Memorial Sloan Kettering Cancer Center, NY, NY
¹¹Clinical Pharmacology Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
¹²Clinical Pharmacology Program, National Cancer Institute, National Institutes of Health, Bethesda, MD
¹³Myeloma Division, Department of Medicine, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL